Daniel Bradshaw
Impact in
- Hepatology top 5%
- Hepatitis C virus research
-
- HIV Research and Treatment
Papers in
-
- Hepatitis C virus research 9
-
- Hepatitis B Virus Studies 4
- Liver Disease Diagnosis and Treatment 2
- Trypanosoma species research and implications 1
- Co-authors
- R.J. Arceci (1 shared paper)Gail Matthews (4 shared papers)Mark Danta (3 shared papers)Jean Fourie (1 shared paper)Krisela Steyn (1 shared paper)Scott M. Ward (1 shared paper)Prabhjeet Phalora (1 shared paper)Heike Leyendeckers (1 shared paper)
- Journals
- The Journal of Infectious Diseases (3 papers)Journal of Viral Hepatitis (2 papers)BMJ Open (2 papers)PLoS ONE (2 papers)HIV Medicine (2 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Daniel Bradshaw
25 papers receiving 505 citations
Peers
Comparison fields: 5 of 78
- Hepatology 134
- Virology 31
- Oncology 147
- Infectious Diseases 93
- Epidemiology 133
Countries citing papers authored by Daniel Bradshaw
This map shows the geographic impact of Daniel Bradshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bradshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bradshaw more than expected).
Fields of papers citing papers by Daniel Bradshaw
This network shows the impact of papers produced by Daniel Bradshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bradshaw. The network helps show where Daniel Bradshaw may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Bradshaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 192 | |
| 2 | 2012 | 84 | |
| 3 | The impact of chronic diseases of lifestyle and their major risk factors on mortality in South Africa. | 1992 | 45 |
| 4 | 2008 | 29 | |
| 5 | 2014 | 28 | |
| 6 | 2021 | 21 | |
| 7 | 2015 | 18 | |
| 8 | 2020 | 16 | |
| 9 | 2021 | 15 | |
| 10 | 2013 | 14 | |
| 11 | 2007 | 10 | |
| 12 | 2016 | 9 | |
| 13 | The current state and future projections of the HIV/AIDS epidemic in South Africa. | 2002 | 9 |
| 14 | 2017 | 8 | |
| 15 | 2020 | 8 | |
| 16 | 2023 | 6 | |
| 17 | 2024 | 6 | |
| 18 | 1962 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2025 | 2 |
About Daniel Bradshaw
Daniel Bradshaw is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Virology and Molecular Biology, having authored 27 papers that have together received 531 indexed citations. Recurring topics across this work include Hepatitis C virus research (9 papers), HIV Research and Treatment (5 papers), Hepatitis B Virus Studies (4 papers), HIV/AIDS drug development and treatment (3 papers), HIV/AIDS Impact and Responses (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Syphilis Diagnosis and Treatment (2 papers) and Trypanosoma species research and implications (1 paper). The work is most often cited by research in Hepatology (134 citations), Virology (31 citations), Oncology (147 citations), Infectious Diseases (93 citations) and Epidemiology (133 citations). Daniel Bradshaw has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include R.J. Arceci, Gail Matthews, Mark Danta, Jean Fourie, Krisela Steyn, Scott M. Ward, Prabhjeet Phalora, Heike Leyendeckers, Paul Klenerman and Tanya Applegate. Their work appears in journals such as The Journal of Infectious Diseases, Journal of Viral Hepatitis, BMJ Open, PLoS ONE and HIV Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.